Suppr超能文献

Nm23蛋白在人乳腺导管原位癌和浸润性癌中的表达

Nm23 protein expression in ductal in situ and invasive human breast carcinoma.

作者信息

Royds J A, Stephenson T J, Rees R C, Shorthouse A J, Silcocks P B

机构信息

Department of Pathology, University of Sheffield, England.

出版信息

J Natl Cancer Inst. 1993 May 5;85(9):727-31. doi: 10.1093/jnci/85.9.727.

Abstract

BACKGROUND

Mortality associated with human breast carcinoma is almost entirely due to subsequent metastatic disease, but the molecular basis of this metastasis is not understood. Elucidation of the genetic control of metastatic propensity of a tumor is important in determining prognosis and choice of therapy. Expression of nm23, a putative metastasis suppressor gene, has been detected in human breast cancers, but studies have not consistently shown high levels of the Nm23 messenger RNA or protein to be associated with better histological differentiation. This inconsistency suggests that Nm23 protein may act independently as a metastasis suppressor.

PURPOSE

The purpose of this retrospective study was to investigate the relationship of Nm23 protein expression with 1) histology in ductal breast carcinoma in situ and 2) the variables considered to be the major prognostic indicators in invasive breast carcinoma.

METHODS

We obtained formalin-fixed biopsy specimens of breast tissue excised from 128 patients with breast lesions detected by mammography. Of these patients, 35 had been diagnosed with benign breast disease, 26 with ductal carcinoma in situ (DCIS), and 67 with invasive carcinoma. Tissue sections were embedded in paraffin blocks, and immunohistochemical staining was used to determine Nm23 expression. Specimens were rated positive if all lesional epithelium was stained and negative if any lesional epithelium was unstained. Statistical analysis was performed by multiple regression analysis because of nonorthogonality of the data.

RESULTS

All 35 examples of benign breast disease showed uniform epithelial cell staining. The seven cases of comedo DCIS were negative for Nm23 protein; all 18 noncomedo types were positive. Nm23 negativity was significantly associated with worsening invasive ductal carcinoma grade and advancing lymph node stage but not with tumor diameter or vascular invasion. Despite the putative antimetastatic role of the nm23 gene, no statistically significant association was found between Nm23 protein expression and vascular invasion.

CONCLUSIONS

The precise role of the nm23 gene remains to be established, but our simplified immunohistochemical rating system shows an association between Nm23 protein expression and the two most significant prognostic factors relating to histologic grade and stage. Nm23 negativity distinguished comedo ductal carcinoma in situ from the other histological types, a finding consistent with the fact that comedo histology is known to have a higher likelihood of becoming invasive and of having higher cell proliferation rates and higher expression of growth factor (c-erb B2) receptor.

摘要

背景

与人类乳腺癌相关的死亡几乎完全归因于随后的转移性疾病,但这种转移的分子基础尚不清楚。阐明肿瘤转移倾向的基因控制对于确定预后和治疗选择很重要。在人类乳腺癌中已检测到假定的转移抑制基因nm23的表达,但研究并未始终表明高水平的Nm23信使核糖核酸或蛋白质与更好的组织学分化相关。这种不一致表明Nm23蛋白可能独立作为转移抑制因子发挥作用。

目的

这项回顾性研究的目的是调查Nm23蛋白表达与1)乳腺导管原位癌的组织学以及2)浸润性乳腺癌中被认为是主要预后指标的变量之间的关系。

方法

我们获取了通过乳房X线摄影检测出乳腺病变的128例患者切除的福尔马林固定的乳腺组织活检标本。在这些患者中,35例被诊断为良性乳腺疾病,26例为导管原位癌(DCIS),67例为浸润性癌。将组织切片包埋在石蜡块中,并用免疫组织化学染色来确定Nm23的表达。如果所有病变上皮均被染色,则标本被评为阳性;如果任何病变上皮未被染色,则标本被评为阴性。由于数据的非正交性,通过多元回归分析进行统计分析。

结果

所有35例良性乳腺疾病均显示上皮细胞均匀染色。7例粉刺型DCIS的Nm23蛋白为阴性;所有18例非粉刺型均为阳性。Nm23阴性与浸润性导管癌分级恶化和淋巴结分期进展显著相关,但与肿瘤直径或血管侵犯无关。尽管nm23基因具有假定的抗转移作用,但未发现Nm23蛋白表达与血管侵犯之间存在统计学上的显著关联。

结论

nm23基因的确切作用仍有待确定,但我们简化的免疫组织化学评分系统显示Nm23蛋白表达与与组织学分级和分期相关的两个最重要的预后因素之间存在关联。Nm23阴性将粉刺型导管原位癌与其他组织学类型区分开来,这一发现与粉刺型组织学已知具有更高的侵袭可能性、更高的细胞增殖率和更高的生长因子(c-erb B2)受体表达这一事实一致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验